Novartis to Acquire Chinook Therapeutics for Up to $3.5 Billion
- June 16, 2023
Swiss drug maker Novartis AG announced June 12 plans to acquire Seattle-based biopharmaceutical firm Chinook Therapeutics for up to $3.5 billion.
ARTICLE TAGS
You must be logged in to access this content.